Cellectar Receives New Financing

  • Feed Type
  • Date
    3/31/2010
  • Company Name
    Cellectar
  • Mailing Address
    3301 Agriculte Drive Madison, WI 53716
  • Company Description
    Capitalizing on the unique characteristics of malignant cancer cells, Cellectar’s molecules are designed to find, treat and follow malignancies through the delivery of radiopharmaceuticals in a novel, highly selective way.
  • Website
    http://www.cellectar.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Advantage Capital Partners

By posting a comment, you agree to our terms and conditions.